ClinConnect ClinConnect Logo
Search / Trial NCT04085848

Music Against Psychological Pain in Suicide

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Sep 9, 2019

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Music Against Psychological Pain in Suicide," is exploring whether music therapy can help reduce feelings of psychological pain in patients who are experiencing suicidal thoughts or have attempted suicide. The study will compare two groups: one that receives standard medical care along with music therapy, and another that only receives standard care. The goal is to see if adding music therapy makes a positive difference in the emotional well-being of these patients.

To participate in this trial, patients need to be between the ages of 65 and 74 and must have current suicidal thoughts or have recently attempted suicide. They should be admitted to a psychiatric hospital voluntarily and able to read and write in French. If eligible, participants can expect to stay in the hospital for about 48 to 60 hours while they receive care, including music therapy sessions. It’s important to note that this study is actively looking for participants, and those who join will be contributing to valuable research that could improve treatment for others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with suicidal ideas, thoughts or surviving suicide attempt
  • Patient whose emergency somatic management lasted less than 48h
  • Patient who, according to the physician, is still in suicidal mood
  • Patient admitted in the psychiatric hospitalization unit of the Public Mental Health Establishment
  • Patient with voluntary admission and agrees to stay in hospital from 48h to 60h
  • Patient able to write and read in french
  • Patient affiliated to a social security scheme
  • Patient who gives his Informed consent before any procedure related to the study
  • Exclusion Criteria:
  • Patient with attempt suicide requiring a somatic care (intensive, surgery, gastric lavage...)
  • Patient with medical history of audiogenic and/or musicogenic epilepsy
  • Patient with major impairment of hearing function
  • Patient unable to support the headhset earphone
  • Patient with contra indication to BZD, hypnotics (Zopiclone) or requiring more sedative and/or psychotic drugs
  • Patient under guardianship or under judicial protection
  • Patient hospitalized at the request of a third party or ex officio

About Centre Hospitalier Universitaire De La Réunion

The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.

Locations

Saint Paul, Réunion

Patients applied

0 patients applied

Trial Officials

Erick GOKALSING

Principal Investigator

EPSMR

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials